References
- Saraswat A, Lahiri K, Chatterjee M, et al. Topical corticosteroid abuse on the face: A prospective, multicenter study of dermatology outpatients. Indian J Dermatol Venereol Leprol 2011; 77:160.
- Sarma P, Kumar H, Medhi B Cosmetovigilance in India: need of the day. Indian J Pharmacol 2017; 49:341.
- Government to come up with list of over-the-counter drugs soon - Times of India [WWW Document]. Times India. cited 16 Dec 2019. https://timesofindia.indiatimes.com/business/india-business/govt-to-come-up-with-list-of-otc-drugs-soon/articleshow/71268127.cms
- M PK, Patil A, AK K, et al. Decoding the roadmap for capacity building of pharmacology academicians in catering to drug information center services in a developing country. J Pharm Technol 2019; 35:146–54.
- Information NC for B, Pike USNL of M 8600 R, MD B, Usa 20894. Eczema: steroids and other topical medications. Institute for Quality and Efficiency in Health Care (IQWiG); 2017. cited 2020 Apr 22. https://www.ncbi.nlm.nih.gov/books/NBK424899/
- Coondoo A, Phiske M, Verma S, et al. Side-effects of topical steroids: A long overdue revisit. Indian Dermatol Online J 2014; 5 :416–25. 4
- Lu H, Xiao T, Lu B, et al. Facial corticosteroid addictive dermatitis in Guiyang City, China. Clin Exp Dermatol 2010; 35(6): 618–21.
- Al-Dhalimi MA, Aljawahiry N Misuse of topical corticosteroids: a clinical study in an Iraqi hospital. East Mediterr Health J Rev Sante Mediterr Orient Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit 2006; 12: 847–52.
- Solomon BA, Glass AT, Rabbin PE Tinea incognito and ‘over-the-counter’ potent topical steroids. Cutis 1996; 58: 295–6.
- Mahé A, Ly F, Aymard G, et al. Skin diseases associated with the cosmetic use of bleaching products in women from Dakar, Senegal. Br J Dermatol 2003; 148(3): 493–500.
- Wagenaar BH, Gimbel S, Hoek R, et al. Wait and consult times for primary healthcare services in central Mozambique: a time-motion study. Glob Health Action 2016; 9(1): 31980.
- Bajpai V The challenges confronting public hospitals in India, their origins, and possible solutions [WWW Document]. Adv. Public Health. 2014; 2014: e898502.
- Khalifeh MM, Moore ND, Salameh PR Self-medication misuse in the Middle East: a systematic literature review. Pharmacol Res Perspect 2017; 5(4): e00323.
- Albsoul-Younes A, Wazaify M, Yousef A-M, et al. Abuse and misuse of prescription and nonprescription drugs sold in community pharmacies in Jordan. Subst Use Misuse 2010; 45(9): 1319–29.
- Elhoseeny TA, Ibrahem SZ, Abo El Ela AM, Abo el Ela AM. Opinion of community pharmacists on use of nonprescription medications in Alexandria, Egypt. J Egypt Public Health Assoc 2013; 88(2): 79–84.
- Jafari F, Khatony A, Rahmani E Prevalence of self-medication among the elderly in Kermanshah-Iran. Glob J Health Sci 2015; 7(2): 360–5.
- Fair RJ, Tor Y Antibiotics and bacterial resistance in the 21st century. Perspect Med Chem 2014; 6: 25–64.
- Tesfamariam S, Anand IS, Kaleab G, et al. Self-medication with over the counter drugs, prevalence of risky practice and its associated factors in pharmacy outlets of Asmara, Eritrea. BMC Public Health 2019; 19:159.
- Latif A Community pharmacy medicines use review: current challenges. Integr Pharm Res Pract 2018; 7: 83–92.
- Chellaiyan VG, Nirupama AY, Taneja N Telemedicine in India: where do we stand? J Fam Med Prim Care 2019; 8(6): 1872–6.
- Adams NE Bloom’s taxonomy of cognitive learning objectives. J Med Libr Assoc JMLA 2015; 103: 152–3.
- Gupta YK, Ramachandran SS Fixed dose drug combinations: issues and challenges in India. Indian J Pharmacol 2016; 48:347.
- Wu C-Y, Hu H-Y, Li C-P, et al. Comorbidity profiles of psoriasis in Taiwan: A latent class analysis. PloS One 2018; 13(2):e0192537.
- Ezzedine K, Le Thuaut A, Jouary T, et al. Latent class analysis of a series of 717 patients with vitiligo allows the identification of two clinical subtypes. Pigment Cell Melanoma Res 2014; 27(1): 134–9.